A study version is represented by a row in the table. Drug: Placebo Placebo will be administered as IV infusion q4w for weeks. Little Rock, Arkansas, United States, Outcome Measures Primary Outcome Measures:. One each from columns A and B. Redlands, California, United States, Mexico City, Mexico, The participants who do not enter open-label extension will enter for a long term follow-up period for up to 52 weeks after the last crenezumab dose Week
© 2020 hyiptrafic.com - All rights reserved. All Models are over 21 y.o.